Management of Undeflatable Coronary Balloons During Percutaneous Coronary Intervention: A Case-Based Review and

Allam Harfoush1,2, Tammam Harfouch3, Muntasir Abo-Al-Hayja4

  • 1Cardiology Department, North Bristol NHS Trust, BS10 5NB Bristol, UK.

Insights

Undeflatable coronary balloons during percutaneous coronary intervention (PCI) are rare but dangerous. A structured approach to troubleshooting, decompression, and retrieval can reduce harm from these critical device failures.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Medical Device Technology

Background:

  • Undeflatable coronary balloons during percutaneous coronary intervention (PCI) are infrequent but pose significant risks.
  • Persistent inflation can lead to abrupt coronary occlusion, ischemia, and hemodynamic compromise.

Purpose of the Study:

  • To synthesize published cases of undeflatable coronary balloons.
  • To define mechanistic patterns and identify predisposing factors.
  • To propose a practical bailout algorithm for managing these events.

Main Methods:

  • A comprehensive literature review of PubMed, Cochrane Library, and EBSCO databases was conducted.
  • Case-based review of reports detailing balloons that could not be deflated in coronary arteries.
  • Analysis of 15 coronary cases from 2011 to 2025.

Main Results:

  • Events commonly occurred during post-dilatation or after stent deployment in complex anatomies (e.g., severe calcification, aorto-ostial lesions).
  • Mechanisms included intact-system non-deflation (manageable with decompression techniques) and shaft-compromised events (requiring retrieval or surgery).
  • Successful management involved restoring perfusion and recognizing shaft integrity early.

Conclusions:

  • Undeflatable balloons have distinct failure modes requiring tailored rescue strategies.
  • Outcomes depend on rapid perfusion restoration and early identification of device integrity.
  • A structured escalation approach, prioritizing stabilization and appropriate intervention, can minimize iatrogenic harm.
Abstract

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...